About Miskolci Egészségügyi Központ
Clinical Trials at Miskolci Egészségügyi Központ
During the past decade, Miskolci Egészségügyi Központ conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Miskolci Egészségügyi Központ
According to Clinical.Site data, the most researched conditions in "Miskolci Egészségügyi Központ" are
"Cicatrix" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "Miskolci Egészségügyi Központ" in a lesser frequency.
Clinical Trials Intervention Types at Miskolci Egészségügyi Központ
Most popular intervention types in "Miskolci Egészségügyi Központ" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Juvista (avotermin)" (1 trials) and "etanercept" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Miskolci Egészségügyi Központ
The vast majority of trials in "Miskolci Egészségügyi Központ" are
2 trials for "All" genders.
Clinical Trials Status at Miskolci Egészségügyi Központ
Currently, there are NaN active trials in "Miskolci Egészségügyi Központ".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Miskolci Egészségügyi Központ,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Miskolci Egészségügyi Központ, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".